Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Binimetinib plus Belinostat for the Treatment of Metastatic Uveal Melanoma

Trial Status: closed to accrual and intervention

This phase II trial tests whether binimetinib and belinostat work to shrink tumors in patients with uveal melanoma that has spread to other places in the body (metastatic). Binimetinib and belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.